Correction: Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study

Meghan R. Hutch, Jiyeon Son, Trang T. Le, Chuan Hong, Xuan Wang, Zahra Shakeri Hossein Abad, Michele Morris, Alba Gutiérrez‐Sacristán, Jeffrey G. Klann, Anastassia Spiridou, Ashley Batugo, Riccardo Bellazzi, Vincent Benoît, Clara-Lea Bonzel, William Bryant, Lorenzo Chiudinelli, Kelly Cho, Priyam Das, Tomás González González, David A. Hanauer, Darren W. Henderson, Yuk‐Lam Ho, Ne Hooi Will Loh, Adeline Makoudjou, Simran Makwana, Alberto Malovini, Bertrand Moal, Danielle L. Mowery, Antoine Neuraz, Malarkodi Jebathilagam Samayamuthu, Fernando J Sanz Vidorreta, Emily Schriver, Petra Schubert, Jeffery Talbert, Amelia L.m. Tan, Byorn W.l. Tan, Bryce W. Q. Tan, Valentina Tibollo, Patric Tippman, Guillaume Verdy, William Yuan, Paul Avillach, Nils Gehlenborg, Gilbert S. Omenn, Shyam Visweswaran, Tianxi Cai, Yuan Luo, Zongqi XiaPLOS 2025 · DOI · OpenAlex

Abstract

This article provides a formal correction to a significant multinational study published in PLOS Digital Health. The correction addresses errors in the original publication's demographic visualizations and data privacy methodology, specifically regarding the "S1 Methods" and the comprehensive demographic breakdown in Figure 2.

Introduction

While COVID-19 is primarily recognized as a respiratory illness, clinical evidence has increasingly shown that it can trigger significant neurological complications. Understanding the global scale of these issues requires harmonizing data across different countries, healthcare systems, and coding practices. This study characterizes the demographic and clinical profiles of patients who develop neurological conditions during COVID-19 hospitalization, categorizing them into no neurological conditions (NNC), central nervous system (CNS) diagnoses, and peripheral nervous system (PNS) diagnoses.

Methodology

The research utilizes a multinational cohort study design, leveraging the Consortium for Clinical Characterization of COVID-19 by EHR (4CE) framework.

  • Data Integration: The study harmonizes Electronic Health Record (EHR) data from diverse international sites across the US, Europe, and Asia.
  • Stratification: Patients are grouped by neurological status: NNC, CNS (e.g., stroke, encephalitis), and PNS (e.g., nerve damage).
  • Privacy Preservation: A key component of the methodology is the obfuscation process. To protect patient confidentiality while maintaining data utility, the researchers applied specific counting and reporting thresholds to the EHR data.

Key Results and Insights

The primary contribution of this correction is the updated demographic visualization, which provides a comprehensive breakdown of the cohort across various international sites.

Demographic and clinical profiles of hospitalized COVID-19 patients across multinational sites, stratified by neurological status.

Global Neurological Impact

The data demonstrates that CNS and PNS diagnoses occurred across every participating healthcare system, regardless of the country or local demographic makeup. The cohort includes tens of thousands of patients, such as over 23,000 at APHP in France and over 10,000 at UPITT in the US.

  • Age Distribution: Patients with CNS and PNS diagnoses often skew toward older age ranges (70-79 and 80+) compared to the NNC group.
  • Adverse Outcomes: Nested pie charts reveal that a higher proportion of patients with neurological diagnoses (particularly CNS) fall into "Severe" and "Deceased" categories. These patients also consistently show higher rates of hospital readmission across most international sites.

Limitations and Future Directions

As an EHR-based study, results depend on the accuracy and consistency of clinical coding across different systems. Additionally, while obfuscation methods protect privacy, they can lead to "Obfuscated" data points in smaller sub-cohorts, slightly limiting granularity for rare conditions. Future research is needed to determine long-term neurological impacts (Long COVID) using this multinational framework as a baseline.

This post summarizes a correction to the article with DOI: 10.1371/journal.pdig.0000484.

Summary updated

Abstract

[This corrects the article DOI: 10.1371/journal.pdig.0000484.].
BibTeX
@inproceedings{hutch2025correction,
  author = {Meghan R. Hutch and Jiyeon Son and Trang T. Le and Chuan Hong and Xuan Wang and Zahra Shakeri Hossein Abad and Michele Morris and Alba Gutiérrez‐Sacristán and Jeffrey G. Klann and Anastassia Spiridou and Ashley Batugo and Riccardo Bellazzi and Vincent Benoît and Clara-Lea Bonzel and William Bryant and Lorenzo Chiudinelli and Kelly Cho and Priyam Das and Tomás González González and David A. Hanauer and Darren W. Henderson and Yuk‐Lam Ho and Ne Hooi Will Loh and Adeline Makoudjou and Simran Makwana and Alberto Malovini and Bertrand Moal and Danielle L. Mowery and Antoine Neuraz and Malarkodi Jebathilagam Samayamuthu and Fernando J Sanz Vidorreta and Emily Schriver and Petra Schubert and Jeffery Talbert and Amelia L.M. Tan and Byorn W.L. Tan and Bryce W. Q. Tan and Valentina Tibollo and Patric Tippman and Guillaume Verdy and William Yuan and Paul Avillach and Nils Gehlenborg and Gilbert S. Omenn and Shyam Visweswaran and Tianxi Cai and Yuan Luo and Zongqi Xia},
  title = {{Correction: Neurological diagnoses in hospitalized COVID-19 patients associated with adverse outcomes: A multinational cohort study}},
  booktitle = {PLOS},
  year = {2025},
  doi = {10.1371/journal.pdig.0000957},
}
Figure